9.17
5.07%
-0.49
Pre-market:
9.29
0.12
+1.31%
Cogent Biosciences Inc Stock (COGT) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
-
|
- | - | - | - |
Research and Development |
8.18%
52.70
|
48.72 | 50.13 | 38.87 | 36.04 |
Costs And Expenses |
7.17%
62.40
|
58.23 | 59.58 | 47.09 | 43.24 |
Depreciation and Amortization |
0.17%
0.599
|
0.598 | 0.581 | 0.562 | 0.529 |
Operating Income/Loss |
7.17%
-62.40
|
-58.23 | -59.58 | -47.09 | -43.24 |
Nonoperating Income/Loss |
5.00%
4.056
|
3.863 | 4.198 | 3.009 | 4.65 |
Income/Loss From Continuing Operations Before Tax |
7.33%
-58.35
|
-54.37 | -59.58 | -44.08 | -38.59 |
Income/Loss From Continuing Operations After Tax |
7.33%
-58.35
|
-54.37 | -55.38 | -44.08 | -38.59 |
Net Income/Loss
|
7.33%
-58.35
|
-54.37 | -55.38 | -44.08 | -38.59 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3,878%
94.80
|
2.3834 | 86.17 | 74.75 | 70.73 |
Diluted Average Shares |
3,878%
94.80
|
2.3834 | 86.17 | 74.75 | 70.73 |
Basic Earnings Per Share |
1.59%
-0.62
|
-0.63 | -0.64 | -0.59 | -0.55 |
Diluted Earnings Per Share |
1.59%
-0.62
|
-0.63 | -0.64 | -0.59 | -0.55 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):